Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction
, 2013 Jessica L. Mega +9 more
openalex +1 more source
Clinical Use of Rivaroxaban: Pharmacokinetic and Pharmacodynamic Rationale for Dosing Regimens in Different Indications [PDF]
, 2014 Toby C. Trujillo, Paul P. Dobesh
openalex +1 more source
Short-term effects of rivaroxaban combined with aspirin in the treatment of lower limb arterial atherosclerosis occlusion with stent placement: A retrospective study. [PDF]
Medicine (Baltimore)Chen J, Chen F, Lu C, Yi S, Xiong W.
europepmc +1 more source
A Novel Synthesis of the Oxazolidinone Antithrombotic Agent Rivaroxaban [PDF]
, 2014 Jianyong Yuan +5 more
openalex +1 more source
Risk of bleeding with the concurrent use of amiodarone and DOACs: a systematic review and meta-analysis. [PDF]
Eur Heart J Cardiovasc PharmacotherMichael F +9 more
europepmc +1 more source
Application of Stability Indicating HPLC Method with UV Detector to the Analysis of Rivaroxaban in Bulk and Tablet Dosage Form [PDF]
, 2014 Burla Sunitha +4 more
openalex +1 more source
Two-week administration of rivaroxaban resolved left atrial thrombus [PDF]
, 2014 Toru Kato +5 more
openalex +1 more source
Comparative Analysis of the Net Clinical Benefit of Direct Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Network Meta-analysis of Randomised Controlled Trials. [PDF]
Eur CardiolDuy Mai T +10 more
europepmc +1 more source
Impact of Anemia Management on Bleeding Outcomes in Anticoagulated Patients: A Retrospective Cohort Analysis. [PDF]
Clin Hematol IntGodin SL, Hanna C, Naut E, Mulay S.
europepmc +1 more source